These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8960544)

  • 1. Potent, selective, orally active 3-oxo-1,4-benzodiazepine GPIIb/IIIa integrin antagonists.
    Samanen JM; Ali FE; Barton LS; Bondinell WE; Burgess JL; Callahan JF; Calvo RR; Chen W; Chen L; Erhard K; Feuerstein G; Heys R; Hwang SM; Jakas DR; Keenan RM; Ku TW; Kwon C; Lee CP; Miller WH; Newlander KA; Nichols A; Parker M; Peishoff CE; Rhodes G; Ross S; Shu A; Simpson R; Takata D; Yellin TO; Uzsinskas I; Venslavsky JW; Yuan CK; Huffman WF
    J Med Chem; 1996 Dec; 39(25):4867-70. PubMed ID: 8960544
    [No Abstract]   [Full Text] [Related]  

  • 2. From peptide to non-peptide. 3. Atropisomeric GPIIbIIIa antagonists containing the 3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione nucleus.
    Blackburn BK; Lee A; Baier M; Kohl B; Olivero AG; Matamoros R; Robarge KD; McDowell RS
    J Med Chem; 1997 Feb; 40(5):717-29. PubMed ID: 9057858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel 2,8-diazaspiro[4.5]decanes as orally active glycoprotein IIb-IIIa antagonists.
    Mehrotra MM; Heath JA; Smyth MS; Pandey A; Rose JW; Seroogy JM; Volkots DL; Nannizzi-Alaimo L; Park GL; Lambing JL; Hollenbach SJ; Scarborough RM
    J Med Chem; 2004 Apr; 47(8):2037-61. PubMed ID: 15056002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New platelet fibrinogen receptor glycoprotein IIb-IIIa antagonists: orally active series of N-alkylated amidines with a 6,6-bicyclic template.
    Okumura K; Shimazaki T; Aoki Y; Yamashita H; Tanaka E; Banba S; Yazawa K; Kibayashi K; Banno H
    J Med Chem; 1998 Oct; 41(21):4036-52. PubMed ID: 9767641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New orally active non-peptide fibrinogen receptor (GpIIb-IIIa) antagonists: identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl) imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]pip erid -4-yl]amino]propionate (SR 121787) as a potent and long-acting antithrombotic agent.
    Badorc A; Bordes MF; de Cointet P; Savi P; Bernat A; Lalé A; Petitou M; Maffrand JP; Herbert JM
    J Med Chem; 1997 Oct; 40(21):3393-401. PubMed ID: 9341914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of action.
    Olson RE; Sielecki TM; Wityak J; Pinto DJ; Batt DG; Frietze WE; Liu J; Tobin AE; Orwat MJ; Di Meo SV; Houghton GC; Lalka GK; Mousa SA; Racanelli AL; Hausner EA; Kapil RP; Rabel SR; Thoolen MJ; Reilly TM; Anderson PS; Wexler RR
    J Med Chem; 1999 Apr; 42(7):1178-92. PubMed ID: 10197962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of an orally active series of isoxazoline glycoprotein IIb/IIIa antagonists.
    Xue CB; Wityak J; Sielecki TM; Pinto DJ; Batt DG; Cain GA; Sworin M; Rockwell AL; Roderick JJ; Wang S; Orwat MJ; Frietze WE; Bostrom LL; Liu J; Higley CA; Rankin FW; Tobin AE; Emmett G; Lalka GK; Sze JY; Di Meo SV; Mousa SA; Thoolen MJ; Racanelli AL; Olson RE
    J Med Chem; 1997 Jun; 40(13):2064-84. PubMed ID: 9207948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of a new class of orally active fibrinogen receptor antagonists.
    Klein SI; Molino BF; Czekaj M; Gardner CJ; Chu V; Brown K; Sabatino RD; Bostwick JS; Kasiewski C; Bentley R; Windisch V; Perrone M; Dunwiddie CT; Leadley RJ
    J Med Chem; 1998 Jul; 41(14):2492-502. PubMed ID: 9651154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycoprotein IIb/IIIa receptor number and occupancy during chronic administration of an oral antagonist.
    Quinn MJ; Cox D; Foley JB; Fitzgerald DJ
    J Pharmacol Exp Ther; 2000 Nov; 295(2):670-6. PubMed ID: 11046104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoprotein IIb/IIIa antagonists in acute coronary syndromes: where are we now?
    Maree A; Fitzgerald DJ
    Semin Vasc Med; 2003 Nov; 3(4):385-90. PubMed ID: 15199445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPIIb/IIIa antagonists: pathophysiologic and therapeutic insights from studies of c7E3 Fab.
    Coller BS
    Thromb Haemost; 1997 Jul; 78(1):730-5. PubMed ID: 9198247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of potent isoxazoline glycoprotein IIb/IIIa receptor antagonists.
    Wityak J; Sielecki TM; Pinto DJ; Emmett G; Sze JY; Liu J; Tobin AE; Wang S; Jiang B; Ma P; Mousa SA; Wexler RR; Olson RE
    J Med Chem; 1997 Jan; 40(1):50-60. PubMed ID: 9016328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists and thrombolytics on platelet/fibrin-mediated clot dynamics in human whole blood using thrombelastography.
    Mousa SA
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):55-60. PubMed ID: 17179828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 2,5-thiazole butanoic acids as potent and selective alpha(v)beta3 integrin receptor antagonists with improved oral pharmacokinetic properties.
    Wendt JA; Wu H; Stenmark HG; Boys ML; Downs VL; Penning TD; Chen BB; Wang Y; Duffin T; Finn MB; Keene JL; Engleman VW; Freeman SK; Hanneke ML; Shannon KE; Nickols MA; Steininger CN; Westlin M; Klover JA; Westlin W; Nickols GA; Russell MA
    Bioorg Med Chem Lett; 2006 Feb; 16(4):845-9. PubMed ID: 16303301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen receptor (GPIIb-IIIa) antagonists derived from 5,6-bicyclic templates. Amidinoindoles, amidinoindazoles, and amidinobenzofurans containing the N-alpha-sulfonamide carboxylic acid function as potent platelet aggregation inhibitors.
    Su T; Naughton MA; Smyth MS; Rose JW; Arfsten AE; McCowan JR; Jakubowski JA; Wyss VL; Ruterbories KJ; Sall DJ; Scarborough RM
    J Med Chem; 1997 Dec; 40(26):4308-18. PubMed ID: 9435900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cold start for oral glycoprotein IIb/IIIa antagonists.
    Curtin R; Fitzgerald DJ
    Eur Heart J; 2000 Dec; 21(24):1992-4. PubMed ID: 11102247
    [No Abstract]   [Full Text] [Related]  

  • 17. GPIIb/IIIa integrin antagonists with the new conformational restriction unit, trisubstituted beta-amino acid derivatives, and a substituted benzamidine structure.
    Hayashi Y; Katada J; Harada T; Tachiki A; Iijima K; Takiguchi Y; Muramatsu M; Miyazaki H; Asari T; Okazaki T; Sato Y; Yasuda E; Yano M; Uno I; Ojima I
    J Med Chem; 1998 Jun; 41(13):2345-60. PubMed ID: 9632368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of conformationally restricted benzamidines as arginine surrogates in the design of platelet GPIIb-IIIa receptor antagonists.
    Sall DJ; Arfsten AE; Bastian JA; Denney ML; Harms CS; McCowan JR; Morin JM; Rose JW; Scarborough RM; Smyth MS; Um SL; Utterback BG; Vasileff RT; Wikel JH; Wyss VL; Jakubowski JA
    J Med Chem; 1997 Aug; 40(18):2843-57. PubMed ID: 9288166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet efficacy of XV459, a novel nonpeptide platelet GPIIb/IIIa antagonist: comparative platelet binding profiles with c7E3.
    Mousa SA; Bozarth JM; Lorelli W; Forsythe MS; Thoolen MJ; Slee AM; Reilly TM; Friedman PA
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1277-84. PubMed ID: 9732389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational preferences in a benzodiazepine series of potent nonpeptide fibrinogen receptor antagonists.
    Keenan RM; Callahan JF; Samanen JM; Bondinell WE; Calvo RR; Chen L; DeBrosse C; Eggleston DS; Haltiwanger RC; Hwang SM; Jakas DR; Ku TW; Miller WH; Newlander KA; Nichols A; Parker MF; Southhall LS; Uzinskas I; Vasko-Moser JA; Venslavsky JW; Wong AS; Huffman WF
    J Med Chem; 1999 Feb; 42(4):545-59. PubMed ID: 10052962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.